AI opens door to safe, effective new antibiotics to combat resistant bacteria
In a hopeful sign for demand for more safe, effective antibiotics for humans, researchers at The University of Texas at Austin have leveraged artificial intelligence to develop a new drug that already is showing promise in animal trials.
Publishing their results in Nature Biomedical Engineering, the scientists describe using a large language model—an AI tool like the one that powers ChatGPT—to engineer a version of a bacteria-killing drug that was previously toxic in humans, so that it would be safe to use.
The prognosis for patients ...














